Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A).

Rice K, Lehtinen N, Välimäki E, Suhonen J, Taimen P, Kettunen K, Ventelä S, Kononen J, Sihto H, Rantala JK

Open source

DOI
10.1007/s00109-026-02677-7
Published
2026 Apr 28
Container
Journal of molecular medicine (Berlin, Germany)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00109-026-02677-7,
  title = {Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A).},
  author = {Rice K and Lehtinen N and Välimäki E and Suhonen J and Taimen P and Kettunen K and Ventelä S and Kononen J and Sihto H and Rantala JK},
  year = {2026},
  journal = {Journal of molecular medicine (Berlin, Germany)},
  doi = {10.1007/s00109-026-02677-7},
  url = {https://doi.org/10.1007/s00109-026-02677-7}
}

RIS

TY  - JOUR
TI  - Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A).
AU  - Rice K
AU  - Lehtinen N
AU  - Välimäki E
AU  - Suhonen J
AU  - Taimen P
AU  - Kettunen K
AU  - Ventelä S
AU  - Kononen J
AU  - Sihto H
AU  - Rantala JK
PY  - 2026
JO  - Journal of molecular medicine (Berlin, Germany)
DO  - 10.1007/s00109-026-02677-7
UR  - https://doi.org/10.1007/s00109-026-02677-7
ER  - 

APA

K, R., N, L., E, V., J, S., P, T., K, K., S, V., J, K., H, S., & JK, R. (2026). Pan-cancer ex vivo target evaluation of phosphodiesterase 3 A (PDE3A).. Journal of molecular medicine (Berlin, Germany). https://doi.org/10.1007/s00109-026-02677-7

Source records